1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease

Technology appraisal guidance [TA449] Published: 28 June 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance